UAU Anegg

U Anegg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


U Anegg has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    P-203TEN-YEAR FOLLOW-UP AFTER RESECTION FOR NON-SMALL CELL LUNG CANCER: WHAT ACTUALLY HAPPENS TO OUR PATIENTS

    by Jörg Lindenmann, N Fink-Neuboeck, C Porubsky, M Fediuk, E Gschwandtner, A Strießnig, P Swatek, U Anegg, A Maier, J Smolle, et al.

    Objectives: Recurrence, second lung primaries, as well as other tumours and accompanying disease influence long-term survival.

  • Open Access

    P-109HOW LONG SHOULD WE FOLLOW UP PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE RESECTION? AN ANALYSIS OF 300 CASES USING FLEXIBLE PARAMETRIC MODELLING OF TUMOUR RECURRENCE AND MORTALITY RATES

    by Jörg Lindenmann, N Fink-Neuboeck, M Fediuk, E Gschwandtner, A Strießnig, P Swatek, M Pichler, F Posch, E Stacher-Priehse, U Anegg, et al.

    Objectives: Among patients with non-small cell lung cancer (NSCLC), those with stage I disease have a comparably favourable prognosis. However, there exists no uniform consensus about the ideal duration of routine follow-up for early detection of postoperative tumour recurrence. The aim of this observational historical cohort study was to obtain guidance on a reasonable duration of aftercare in this patient population.

  • Open Access

    P-142PREDICTION OF CLINICAL OUTCOMES IN STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE SURGERY FOCUSING ON THE PREOPERATIVE GLASGOW PROGNOSTIC SCORE AND INFLAMMATORY BIOMARKERS

    by Jörg Lindenmann, N Fink-Neuboeck, M Fediuk, E Gschwandtner, P Swatek, A Strießnig, M Pichler, F Posch, E Stacher-Priehse, U Anegg, et al.

    Objectives: The Glasgow Prognostic Score (GPS), an “inflammatory” prognostic index incorporating low serum albumin and elevated C-reactive protein, predicts overall survival (OS) in patients with non-small cell lung cancer (NSCLC). The aim of this study was to validate this preoperative score in a large population of patients with resected NSCLC stage I.

  • Stress-induced hormonal and mood responses in scuba divers

    by U Anegg, G Dietmaier, A Maier, F Tomaselli, S Gabor, K.W Kallus, F.M Smolle-Jüttner


    • 27 October 2001
      • Vol. 48  (41) , 1368-71

    Boerhaave's syndrome: a continuing challenge in thoracic surgery.

    by A Maier, H Pinter, U Anegg, B Fell, F Tomaselli, O Sankin, F M Smolle-Jüttner

    Boerhaave's syndrome accounts for 30-40% of esophageal disruption. The current literature regarding the management of these patients and problems in treatment remains controversial. Between 1988 and 1998, 14 patients with Boerhaave's syndrome were treated in our unit. Five primary repairs and 9 esophagectomies were performed. A retrospective review of these patients' records was carried out. The patients were divided into two groups. Group I: minor esophageal leak, local mediastinitis and hyperdynamic septic shock. All 5 cases were treated by primary repair. Group II: moderate to severe esophageal leak, severe mediastinitis and hypodynamic septic shock. All 9 cases were treated by transthoracic esophagectomy. Group I: No postoperative mortality. The mean ICU stay was 4.6 days. The mean hospitalization time was 14 days. Group II: The postoperative mortality was 22.2%. The mean ICU stay was 28 days. The mean hospitalization time was 45 days. The choice of which operative approach should be made in patients with Boerhaave's syndrome requires critical assessment of the patient's overall status, the duration of leak and the extent of mediastinal and pleural contamination.


    • 21 July 2001
      • Vol. 48  (39) , 899-902

    Acid-related diseases following retrosternal stomach interposition.

    by A Maier, F Tomaselli, O Sankin, U Anegg, B Fell, H Renner, H Pinter, G B Friehs, F M Smolle-Jüttner

    Esophagectomy and reconstruction with retrosternal stomach interposition implies bilateral truncal vagotomy, which supposedly causes gastric functional impairment. Esophagectomy and reconstruction with retrosternal stomach interposition was performed on 15 men (mean age: 58.4 years) and 3 women (mean age: 43.6 years). The stomach was pedicled on the right gastric and right gastroepiploic artery without performing pyloroplasty. The cervical side-to-end anastomosis was sutured manually. The functional results were assessed 2-4 years postoperatively, by determining 24-hour qualitative intragastric pH-measurement, fluoroscopical gastric emptying studies, fasting gastrin levels, and endoscopy with biopsy studies. Endoscopy and biopsy confirmed esophagitis in 12 patients, gastritis in 15 and a gastric ulcer in 1 case. Fluoroscopic examination documented a normal passage of contrast medium in 17, slight impairment in 1 case treated by balloon dilatation of the pylorus. Qualitative intragastric pH-measurement revealed a total pH < 3 in 22.5-98.05% of measuring events (mean: 74.31%) within 24 hours, in 18 cases. Only 4 patients had pH < 3 in less than 50%. Fasting gastrin levels (normal range: 25-110 mU/L) varied from 48.78 mU/L-168.20 (mean: 85.23 mU/L). Only 3 patients had levels > 110 mU/L (maximum: 168.20 mU/L). Acid-related diseases may also occur after truncal vagotomy and retrosternal stomach interposition. Routine follow-up endoscopy and biopsy studies should be done to prevent inflammatory complications and maintain the patient's quality of life.


  • The effect of external beam irradiation after endoscopic palliation of esophageal carcinoma.

    by A Maier, U Anegg, R Lunzer, U Prettenhofer, P Rehak, O Sankin, B Fell, H Pinter, F M Smolle-Juttner

    The aim of this study was to verify the value of additional external beam irradiation (EBR) after endoscopic palliation, regarding quality of life and survival rate. From January 1988 to December 1995, 99 patients with esophageal carcinoma (squamous cell carcinoma 61; adenocarcinoma 38) were reviewed, there were 84 males (mean age: 67 years) and 16 females (mean age: 65 years). Seventeen patients were in stage IIb, 45 stage III and 37 patients in stage IV. HDR-brachyradiotherapy (mean: 14.7 Gy) was carried out in all patients. Additional EBR (mean: 47.8 Gy) after endoluminal palliation was done in 51 cases. At 6-months follow-up swallowing of a semi-solid diet at least was possible in all patients and dysphagia was found with significant difference in favour to EBR only in stage IV (p=0.011). The Karnovsky performance status showed a difference in favour of EBR for stage III and IV (p=0.040 and p=0. 049, respectively). The median overall survival for EBR compared to no EBR was 10 and 7 months, with a 12 months survival rate of 60% and 16% (p=0.0012). However, considering different stages and EBR versus no EBR a significant difference in survival could only be found for stage IIb (p=0.031), a trend in favour of EBR could be found for stage III (p=0.0985) and stage IV (p=0.0543). Tumor regrowth 6-12 months after treatment occurred in 31 cases and was successfully treated with Nd-YAG laser in 25 and stenting in 6 cases. Postirradiation fibrotic stenosis occurred in 12 cases. Improved survival rates after additional EBR can only be expected in stage IIb. However, in case of advanced esophageal carcinoma and fair performance status, EBR after endoluminal palliation help to maintain quality of life.